These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

715 related items for PubMed ID: 9818934

  • 21. Axonal damage in Guillain-Barré syndrome.
    van der Meché FG, Meulstee J, Kleyweg RP.
    Muscle Nerve; 1991 Oct; 14(10):997-1002. PubMed ID: 1944413
    [Abstract] [Full Text] [Related]

  • 22. The spectrum of acquired demyelinating polyradiculoneuropathy.
    Hughes RA.
    Acta Neurol Belg; 1994 Oct; 94(2):128-32. PubMed ID: 8036880
    [Abstract] [Full Text] [Related]

  • 23. Guillain-Barré syndrome: multifactorial mechanisms versus defined subgroups.
    van der Meché FG, Visser LH, Jacobs BC, Endtz HP, Meulstee J, van Doorn PA.
    J Infect Dis; 1997 Dec; 176 Suppl 2():S99-102. PubMed ID: 9396690
    [Abstract] [Full Text] [Related]

  • 24. Guillain-Barré syndrome: clinical neurophysiologic studies.
    Cros D, Triggs WJ.
    Rev Neurol (Paris); 1996 May; 152(5):339-43. PubMed ID: 8881426
    [Abstract] [Full Text] [Related]

  • 25. [Prognosis in Guillain-Barre syndrome assessed by clinical and neurophysiological features].
    Smith TA.
    Ugeskr Laeger; 2000 Sep 04; 162(36):4805-7. PubMed ID: 10994378
    [Abstract] [Full Text] [Related]

  • 26. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group.
    van der Meché FG, Schmitz PI.
    N Engl J Med; 1992 Apr 23; 326(17):1123-9. PubMed ID: 1552913
    [Abstract] [Full Text] [Related]

  • 27. [Guillain-Barre syndrome and its frontiers].
    Azulay JP, Verschueren A, Attarian S, Pouget J.
    Rev Neurol (Paris); 2002 Dec 23; 158(12 Pt 2):S21-6. PubMed ID: 12690657
    [Abstract] [Full Text] [Related]

  • 28. Use of immunoglobulin in severe childhood Guillain-Barré syndrome.
    Ortiz-Corredor F, Peña-Preciado M.
    Acta Neurol Scand; 2007 Apr 23; 115(4):289-93. PubMed ID: 17376129
    [Abstract] [Full Text] [Related]

  • 29. Electrophysiological studies in Guillain-Barré syndrome: correlation with antibodies to GM1, GD1B and Campylobacter jejuni.
    Vriesendorp FJ, Triggs WJ, Mayer RF, Koski CL.
    J Neurol; 1995 Jul 23; 242(7):460-5. PubMed ID: 7595678
    [Abstract] [Full Text] [Related]

  • 30. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
    Caudie C, Vial C, Petiot P, Bancel J, Later R, Gonnaud PM.
    Ann Biol Clin (Paris); 1999 Jul 23; 57(5):579-88. PubMed ID: 10518060
    [Abstract] [Full Text] [Related]

  • 31. Inflammatory-demyelinating polyneuropathies.
    Feasby TE.
    Neurol Clin; 1992 Aug 23; 10(3):651-70. PubMed ID: 1323748
    [Abstract] [Full Text] [Related]

  • 32. Conduction block--the diagnostic value in the early stage of Guillain-Barre syndrome.
    Atanasova D, Ishpekova B, Muradyan N, Novachkova S, Daskalov M.
    Electromyogr Clin Neurophysiol; 2004 Sep 23; 44(6):361-4. PubMed ID: 15473348
    [Abstract] [Full Text] [Related]

  • 33. Asymmetric Guillain-Barré syndrome.
    Logullo F, Manicone M, Di Bella P, Provinciali L.
    Neurol Sci; 2006 Nov 23; 27(5):355-9. PubMed ID: 17122947
    [Abstract] [Full Text] [Related]

  • 34. Multifocal motor neuropathy: current concepts and controversies.
    Nobile-Orazio E, Cappellari A, Priori A.
    Muscle Nerve; 2005 Jun 23; 31(6):663-80. PubMed ID: 15770650
    [Abstract] [Full Text] [Related]

  • 35. Treatment of immune-mediated, dysimmune neuropathies.
    Finsterer J.
    Acta Neurol Scand; 2005 Aug 23; 112(2):115-25. PubMed ID: 16008538
    [Abstract] [Full Text] [Related]

  • 36. Follow-up study and response to treatment in 23 patients with Lewis-Sumner syndrome.
    Viala K, Renié L, Maisonobe T, Béhin A, Neil J, Léger JM, Bouche P.
    Brain; 2004 Sep 23; 127(Pt 9):2010-7. PubMed ID: 15289267
    [Abstract] [Full Text] [Related]

  • 37. Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside.
    Yuki N, Yamada M, Koga M, Odaka M, Susuki K, Tagawa Y, Ueda S, Kasama T, Ohnishi A, Hayashi S, Takahashi H, Kamijo M, Hirata K.
    Ann Neurol; 2001 Jun 23; 49(6):712-20. PubMed ID: 11409422
    [Abstract] [Full Text] [Related]

  • 38. Motor nerve inexcitability in Guillain-Barré syndrome. The spectrum of distal conduction block and axonal degeneration.
    Triggs WJ, Cros D, Gominak SC, Zuniga G, Beric A, Shahani BT, Ropper AH, Roongta SM.
    Brain; 1992 Oct 23; 115 ( Pt 5)():1291-302. PubMed ID: 1422789
    [Abstract] [Full Text] [Related]

  • 39. [4 cases of Guillain-Barré syndrome with axonal lesions].
    Vallat JM, Hugon J, Tabaraud F, Leboutet MJ, Chazot F, Dumas M.
    Rev Neurol (Paris); 1990 Oct 23; 146(6-7):420-4. PubMed ID: 2399405
    [Abstract] [Full Text] [Related]

  • 40. Demyelination induced by serum from patients with Guillain-Barré syndrome.
    Harrison BM, Hansen LA, Pollard JD, McLeod JG.
    Ann Neurol; 1984 Feb 23; 15(2):163-70. PubMed ID: 6703656
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 36.